Presentation Title: Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass and Physical Function in Older Patients Receiving Semaglutide for Weight Loss Date: April 30, 2025 Start time: 12:30 ...

Werewolf Therapeutics (HOWL) announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings more than 35 years of experience ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in ...

UK-headquartered Beacon Therapeutics has raised a whopping $170 million in second-round financing that will be used to advance a gene therapy for an inherited cause of blindness through a pivotal ...

PENNINGTON, N.J. and QUÉBEC, April 16, 2025 /CNW/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Feldan ...

Ceva, Inc. , the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, will announce results for the first quarter ...

Smartkem , which is seeking to change the world of electronics with a new class of transistor technology, announced it will exhibit and its CEO will give a presentation at Display Week 2025 taking ...

Black Beacon is the newest title from publisher Glohow that recently launched on mobile devices. It’s a mythic sci-fi action RPG with a story that sees you travel through time and visit ...

Other therapies directed at specific mutations – including Ocugen’s OCU400, Beacon Therapeutics’ AGTC-501, and Frontera Therapeutics’ FT-002 – are in clinical trials. Thousands of ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...